Hangzhou Alltest Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Hangzhou Alltest Biotech has a total shareholder equity of CN¥3.8B and total debt of CN¥11.9M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥4.1B and CN¥298.1M respectively. Hangzhou Alltest Biotech's EBIT is CN¥116.8M making its interest coverage ratio -14.3. It has cash and short-term investments of CN¥2.7B.
Key information
0.3%
Debt to equity ratio
CN¥11.92m
Debt
| Interest coverage ratio | -14.3x |
| Cash | CN¥2.71b |
| Equity | CN¥3.84b |
| Total liabilities | CN¥298.05m |
| Total assets | CN¥4.14b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688606's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥285.9M).
Long Term Liabilities: 688606's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥12.1M).
Debt to Equity History and Analysis
Debt Level: 688606 has more cash than its total debt.
Reducing Debt: 688606's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: 688606's debt is well covered by operating cash flow (2026%).
Interest Coverage: 688606 earns more interest than it pays, so coverage of interest payments is not a concern.